Literature DB >> 20625376

Cortical lesions in multiple sclerosis.

Massimiliano Calabrese1, Massimo Filippi, Paolo Gallo.   

Abstract

Multiple sclerosis (MS) is typically considered to be a chronic inflammatory-demyelinating disease of CNS white matter. In the past decade, however, pathological and MRI studies have shown that lesions are often located in the gray matter, especially in the cerebral cortex. The histopathological characteristics of these cortical lesions differ substantially from lesions located in the white matter, which suggests location-dependent expression of the MS immunopathological process. Double inversion recovery imaging--an MRI technique that selectively images gray matter and lesions--has enabled researchers to image cortical lesions in vivo. Double inversion recovery studies have shown that cortical lesions can be detected at the earliest clinical stages of MS, and cortical lesion burden positively correlates with the severity of physical and cognitive impairments. These gray matter lesions are also independent predictors of subsequent disease evolution. This Review provides a summary of the main histopathological and MRI findings with regard to cortical lesions in MS, and indicates that increasing our understanding of cortical lesions has increased our knowledge of MS pathobiology.

Entities:  

Mesh:

Year:  2010        PMID: 20625376     DOI: 10.1038/nrneurol.2010.93

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  57 in total

1.  The distribution of plaques in the cerebrum in multiple sclerosis.

Authors:  B BROWNELL; J T HUGHES
Journal:  J Neurol Neurosurg Psychiatry       Date:  1962-11       Impact factor: 10.154

2.  Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology.

Authors:  Jeroen J G Geurts; Lars Bö; Petra J W Pouwels; Jonas A Castelijns; Chris H Polman; Frederik Barkhof
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

3.  A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis.

Authors:  Massimiliano Calabrese; Maria A Rocca; Matteo Atzori; Irene Mattisi; Alice Favaretto; Paola Perini; Paolo Gallo; Massimo Filippi
Journal:  Ann Neurol       Date:  2010-03       Impact factor: 10.422

4.  Gray matter atrophy in multiple sclerosis: a longitudinal study.

Authors:  Elizabeth Fisher; Jar-Chi Lee; Kunio Nakamura; Richard A Rudick
Journal:  Ann Neurol       Date:  2008-09       Impact factor: 10.422

5.  Substantial archaeocortical atrophy and neuronal loss in multiple sclerosis.

Authors:  Dimitrios Papadopoulos; Sumayya Dukes; Ryan Patel; Richard Nicholas; Abhilash Vora; Richard Reynolds
Journal:  Brain Pathol       Date:  2008-05-20       Impact factor: 6.508

6.  Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration.

Authors:  L Bø; C A Vedeler; H Nyland; B D Trapp; S J Mørk
Journal:  Mult Scler       Date:  2003-08       Impact factor: 6.312

7.  Gray and white matter volume changes in early RRMS: a 2-year longitudinal study.

Authors:  M Tiberio; D T Chard; D R Altmann; G Davies; C M Griffin; W Rashid; J Sastre-Garriga; A J Thompson; D H Miller
Journal:  Neurology       Date:  2005-03-22       Impact factor: 9.910

8.  Evidence of early cortical atrophy in MS: relevance to white matter changes and disability.

Authors:  N De Stefano; P M Matthews; M Filippi; F Agosta; M De Luca; M L Bartolozzi; L Guidi; A Ghezzi; E Montanari; A Cifelli; A Federico; S M Smith
Journal:  Neurology       Date:  2003-04-08       Impact factor: 9.910

9.  Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes.

Authors:  Catherine M Dalton; Declan T Chard; Gerard R Davies; Katherine A Miszkiel; Dan R Altmann; Kryshani Fernando; Gordon T Plant; Alan J Thompson; David H Miller
Journal:  Brain       Date:  2004-03-03       Impact factor: 13.501

10.  Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis.

Authors:  D T Chard; C M Griffin; M A McLean; P Kapeller; R Kapoor; A J Thompson; D H Miller
Journal:  Brain       Date:  2002-10       Impact factor: 13.501

View more
  69 in total

1.  Population-wide principal component-based quantification of blood-brain-barrier dynamics in multiple sclerosis.

Authors:  Russell T Shinohara; Ciprian M Crainiceanu; Brian S Caffo; María Inés Gaitán; Daniel S Reich
Journal:  Neuroimage       Date:  2011-05-23       Impact factor: 6.556

2.  In vivo evidence of disseminated subpial T2* signal changes in multiple sclerosis at 7 T: a surface-based analysis.

Authors:  J Cohen-Adad; T Benner; D Greve; R P Kinkel; A Radding; B Fischl; B R Rosen; C Mainero
Journal:  Neuroimage       Date:  2011-04-13       Impact factor: 6.556

Review 3.  Multiple sclerosis in 2011: Advances in therapy, imaging and risk factors in MS.

Authors:  Bianca Weinstock-Guttman; Murali Ramanathan
Journal:  Nat Rev Neurol       Date:  2012-01-10       Impact factor: 42.937

4.  Comparison of Multiple Sclerosis Cortical Lesion Types Detected by Multicontrast 3T and 7T MRI.

Authors:  J Maranzano; M Dadar; D A Rudko; D De Nigris; C Elliott; J S Gati; S A Morrow; R S Menon; D L Collins; D L Arnold; S Narayanan
Journal:  AJNR Am J Neuroradiol       Date:  2019-06-20       Impact factor: 3.825

5.  Visualization of intra-thalamic nuclei with optimized white-matter-nulled MPRAGE at 7T.

Authors:  Thomas Tourdias; Manojkumar Saranathan; Ives R Levesque; Jason Su; Brian K Rutt
Journal:  Neuroimage       Date:  2013-09-07       Impact factor: 6.556

Review 6.  Secondary Progressive Multiple Sclerosis: Definition and Measurement.

Authors:  Domenico Plantone; Floriana De Angelis; Anisha Doshi; Jeremy Chataway
Journal:  CNS Drugs       Date:  2016-06       Impact factor: 5.749

7.  MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry.

Authors:  Kerstin Bendfeldt; Bernd Taschler; Laura Gaetano; Philip Madoerin; Pascal Kuster; Nicole Mueller-Lenke; Michael Amann; Hugo Vrenken; Viktor Wottschel; Frederik Barkhof; Stefan Borgwardt; Stefan Klöppel; Eva-Maria Wicklein; Ludwig Kappos; Gilles Edan; Mark S Freedman; Xavier Montalbán; Hans-Peter Hartung; Christoph Pohl; Rupert Sandbrink; Till Sprenger; Ernst-Wilhelm Radue; Jens Wuerfel; Thomas E Nichols
Journal:  Brain Imaging Behav       Date:  2019-10       Impact factor: 3.978

Review 8.  Imaging as an Outcome Measure in Multiple Sclerosis.

Authors:  Daniel Ontaneda; Robert J Fox
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

9.  Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions of corpus callosum and cerebral cortex.

Authors:  Martine El-Etr; Marion Rame; Celine Boucher; Abdel M Ghoumari; Narender Kumar; Philippe Liere; Antoine Pianos; Michael Schumacher; Regine Sitruk-Ware
Journal:  Glia       Date:  2014-08-04       Impact factor: 7.452

10.  Lipoic acid reduces inflammation in a mouse focal cortical experimental autoimmune encephalomyelitis model.

Authors:  Priya Chaudhary; Gail Marracci; Danielle Galipeau; Edvinas Pocius; Brooke Morris; Dennis Bourdette
Journal:  J Neuroimmunol       Date:  2015-11-11       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.